Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-03-22
DOI
10.3389/fcimb.2019.00069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improvement of antibody functionality by structure-guided paratope engraftment
- (2019) Qingbo Liu et al. Nature Communications
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
- (2018) Youry Kim et al. Cell Host & Microbe
- CRISPR RNAs trigger innate immune responses in human cells
- (2018) Sojung Kim et al. GENOME RESEARCH
- CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection
- (2018) Lijuan Yin et al. HUMAN GENE THERAPY
- Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
- (2018) Szu-Han Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas
- (2018) Adam L. Mefferd et al. VIROLOGY
- Genome scale screening identification of SaCas9/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection
- (2018) Qiankun Wang et al. VIRUS RESEARCH
- CRISPR-Cas based antiviral strategies against HIV-1
- (2018) Gang Wang et al. VIRUS RESEARCH
- Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
- (2018) Gilles Darcis et al. Viruses-Basel
- CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
- (2018) Shuliang Chen et al. Viruses-Basel
- HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies
- (2018) Shuai Liu et al. Scientific Reports
- Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology
- (2018) Chunxia Qi et al. Molecular Therapy-Nucleic Acids
- HIV-2/SIV viral protein X counteracts HUSH repressor complex
- (2018) Ghina Chougui et al. Nature Microbiology
- NONO Detects the Nuclear HIV Capsid to Promote cGAS-Mediated Innate Immune Activation
- (2018) Xavier Lahaye et al. CELL
- Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments
- (2018) Michelle L. Kimberland et al. JOURNAL OF BIOTECHNOLOGY
- Combination therapy with anti-HIV-1 antibodies maintains viral suppression
- (2018) Pilar Mendoza et al. NATURE
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
- (2018) Yotam Bar-On et al. NATURE MEDICINE
- Cas9 immunity creates challenges for CRISPR gene editing therapies
- (2018) Julie M. Crudele et al. Nature Communications
- Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex
- (2018) Leonid Yurkovetskiy et al. Nature Microbiology
- Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics
- (2018) Brittany E. Givens et al. AAPS Journal
- PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction
- (2018) Wei Zhou et al. HUMAN MOLECULAR GENETICS
- HIV-1 Antisense Protein of Different Clades Induces Autophagy and Associates with the Autophagy Factor p62
- (2018) Zhenlong Liu et al. JOURNAL OF VIROLOGY
- Gene therapy reduces Parkinson’s disease symptoms by reorganizing functional brain connectivity
- (2018) Martin Niethammer et al. Science Translational Medicine
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
- (2018) Philippe E. Mangeot et al. Nature Communications
- CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus
- (2018) Amanda R. Panfil et al. Frontiers in Microbiology
- Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP
- (2018) Shan Jiang et al. Translational Psychiatry
- From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
- (2018) Mahesh Chemudupati et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection
- (2017) Ai Yu et al. Molecular Medicine Reports
- CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
- (2017) Lei Xu et al. MOLECULAR THERAPY
- In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models
- (2017) Chaoran Yin et al. MOLECULAR THERAPY
- Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection
- (2017) Qiankun Wang et al. Retrovirology
- Nucleic acid detection with CRISPR-Cas13a/C2c2
- (2017) Jonathan S. Gootenberg et al. SCIENCE
- CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
- (2017) Suk See De Ravin et al. Science Translational Medicine
- Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection
- (2017) Zhepeng Liu et al. Cell and Bioscience
- SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV
- (2017) Gracia Viviana Gonzalez-Enriquez et al. Journal of Immunology Research
- A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape
- (2017) Robert Jan Lebbink et al. Scientific Reports
- HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay
- (2016) Sara Sunshine et al. JOURNAL OF VIROLOGY
- Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
- (2016) Sheena M Saayman et al. MOLECULAR THERAPY
- CRISPR-mediated Activation of Latent HIV-1 Expression
- (2016) Prajit Limsirichai et al. MOLECULAR THERAPY
- CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
- (2016) Gang Wang et al. MOLECULAR THERAPY
- Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter
- (2016) Haiyan Ji et al. MOLECULAR THERAPY
- Persistent HIV-1 replication maintains the tissue reservoir during therapy
- (2016) Ramon Lorenzo-Redondo et al. NATURE
- CRISPR gene-editing tested in a person for the first time
- (2016) David Cyranoski NATURE
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic
- (2016) Elodie Cassan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CRISPR/Cas9: a double-edged sword when used to combat HIV infection
- (2016) Chen Liang et al. Retrovirology
- A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures
- (2016) Gang Wang et al. Cell Reports
- CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape
- (2016) Zhen Wang et al. Cell Reports
- Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
- (2016) Sam Afkhami et al. Molecular Therapy-Methods & Clinical Development
- The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication
- (2016) Victoria E. Walker-Sperling et al. EBioMedicine
- Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
- (2016) Héloïse M. Delagrèverie et al. Open Forum Infectious Diseases
- Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems
- (2016) Julia K. Bialek et al. PLoS One
- The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery
- (2016) Francesco Cardarelli et al. Scientific Reports
- Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9
- (2016) Kristine E. Yoder et al. Scientific Reports
- Negative Feedback Regulation of HIV-1 by Gene Editing Strategy
- (2016) Rafal Kaminski et al. Scientific Reports
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- Challenges in CRISPR/CAS9 Delivery: Potential Roles of Nonviral Vectors
- (2015) Ling Li et al. HUMAN GENE THERAPY
- MicroRNA-155 Reinforces HIV Latency
- (2015) Debbie S. Ruelas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier
- (2015) C. Fornaguera et al. JOURNAL OF CONTROLLED RELEASE
- Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
- (2015) Chang Li et al. JOURNAL OF GENERAL VIROLOGY
- CRISPR-Cas9 for medical genetic screens: applications and future perspectives
- (2015) Hui-Ying Xue et al. JOURNAL OF MEDICAL GENETICS
- Genome editing strategies: potential tools for eradicating HIV-1/AIDS
- (2015) Kamel Khalili et al. JOURNAL OF NEUROVIROLOGY
- HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation
- (2015) Annachiara Rosa et al. NATURE
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors
- (2015) Xiaoling Wang et al. NATURE BIOTECHNOLOGY
- Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
- (2015) Kathrin Schumann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators
- (2015) Hal P. Bogerd et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
- (2015) Weijun Zhu et al. Retrovirology
- Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
- (2015) Hsin-Kai Liao et al. Nature Communications
- Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
- (2015) Panpan Hou et al. Scientific Reports
- CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs
- (2015) Yonggang Zhang et al. Scientific Reports
- HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells
- (2015) Leonard Chavez et al. PLoS Pathogens
- CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus
- (2015) HyunJun Kang et al. Molecular Therapy-Nucleic Acids
- Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
- (2014) Hiroshi Nishimasu et al. CELL
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
- (2014) Luke A. Gilbert et al. CELL
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Genome-wide identification of CRISPR/Cas9 off-targets in human genome
- (2014) Jinzhi Duan et al. CELL RESEARCH
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Eradication of human immunodeficiency virus from brain reservoirs
- (2014) Avindra Nath JOURNAL OF NEUROVIROLOGY
- Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
- (2014) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- CRISPR-Cas systems for editing, regulating and targeting genomes
- (2014) Jeffry D Sander et al. NATURE BIOTECHNOLOGY
- New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
- (2014) C Korin Bullen et al. NATURE MEDICINE
- Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects
- (2014) Bin Shen et al. NATURE METHODS
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection
- (2014) Weiming Wang et al. PLoS One
- Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection
- (2014) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
- (2014) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
- (2014) Alison L. Hill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The microRNA miR-29a is associated with human immunodeficiency virus latency
- (2014) Paresh Patel et al. Retrovirology
- Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation
- (2014) M. Jinek et al. SCIENCE
- Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway
- (2014) Nathan L. Bowers et al. PLoS Pathogens
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
- (2013) C. A. Didigu et al. BLOOD
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
- (2013) Ya-Chi Ho et al. CELL
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- (2013) Luke A. Gilbert et al. CELL
- Epigenetic Regulation of HIV-1 Latency in Astrocytes
- (2013) S. D. Narasipura et al. JOURNAL OF VIROLOGY
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
- (2013) Seung Woo Cho et al. NATURE BIOTECHNOLOGY
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells
- (2013) Xiying Qu et al. NUCLEIC ACIDS RESEARCH
- Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis
- (2013) Samuel Nyamweya et al. REVIEWS IN MEDICAL VIROLOGY
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers
- (2013) Madhavan Nair et al. Nature Communications
- Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
- (2013) Hirotaka Ebina et al. Scientific Reports
- Origins of HIV and the AIDS Pandemic
- (2013) P. M. Sharp et al. Cold Spring Harbor Perspectives in Medicine
- Pre-existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy
- (2013) Vedell Louis Jeune et al. Human Gene Therapy Methods
- Zinc-finger Nuclease Editing of Human cxcr4 Promotes HIV-1 CD4+ T Cell Resistance and Enrichment
- (2012) Jinyun Yuan et al. MOLECULAR THERAPY
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Chromatin Reassembly Factors Are Involved in Transcriptional Interference Promoting HIV Latency
- (2011) E. Gallastegui et al. JOURNAL OF VIROLOGY
- Acute HIV-1 Infection
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases
- (2011) Craig B. Wilen et al. PLoS Pathogens
- Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation
- (2010) K. Allers et al. BLOOD
- Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
- (2010) Nathalia Holt et al. NATURE BIOTECHNOLOGY
- CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritis
- (2010) Soo-Hyun Chung et al. ARTHRITIS RESEARCH & THERAPY
- AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
- (2009) F. Mingozzi et al. BLOOD
- Short motif sequences determine the targets of the prokaryotic CRISPR defence system
- (2009) MICROBIOLOGY-SGM
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency
- (2008) Tina Lenasi et al. Cell Host & Microbe
- Immunity to adeno-associated virus vectors in animals and humans: a continued challenge
- (2008) A K Zaiss et al. GENE THERAPY
- APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells
- (2008) F.-x. Wang et al. JOURNAL OF GENERAL VIROLOGY
- Genetic Deficiency of Chemokine Receptor CCR5 Is a Strong Risk Factor for Symptomatic West Nile Virus Infection: A Meta‐Analysis of 4 Cohorts in the US Epidemic
- (2008) Jean K. Lim et al. JOURNAL OF INFECTIOUS DISEASES
- Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
- (2008) Tae‐Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
- (2008) Elena E Perez et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started